Cleared Traditional

K212183 - STA R Max 3, STA Compact Max 3 (FDA 510(k) Clearance)

Jun 2023
Decision
694d
Days
Class 2
Risk

K212183 is an FDA 510(k) clearance for the STA R Max 3, STA Compact Max 3. This device is classified as a System, Multipurpose For In Vitro Coagulation Studies (Class II - Special Controls, product code JPA).

Submitted by Diagnostica Stago S.A.S (Asniéres Sur Seine, FR). The FDA issued a Cleared decision on June 7, 2023, 694 days after receiving the submission on July 13, 2021.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.5425.

Submission Details

510(k) Number K212183 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 13, 2021
Decision Date June 07, 2023
Days to Decision 694 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code JPA - System, Multipurpose For In Vitro Coagulation Studies
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.5425